AGENDA - Specialized Workshop Th2 - Thursday Sep. 30, 2021: 8am - 5pm

"Cytometry Innovation Day: Novel Techniques & Advanced Approaches in Cytometry"

High Dimensional/High Parameter Flow Cytometry, new applications of Automated Gating, Advancements in Full Spectrum/Spectral Cytometry, Novel applications of Mass Cytometry, overcoming the barriers in implementation of Imaging Cytometry, Advanced Flow Cytometry for Vaccine application, single‐cell multimodal omics & Highly Multiplexed Flow Cytometry

07:00am–08:00am: Start your day at WRIB with Continental Breakfast

Session 1: Advancements of Mass Cytometry and Imaging Cytometry in Clinical Applications

Chair: Dr. Susan Spitz, Senior Director Translational Sciences, Incyte
08:00am-08:20am: Dr. Polina Goihberg, Discipline Lead BioMedicine Design Department, Pfizer
"Imaging Cytometry in Drug Development: Quantitative Analysis of Target Engagement and Intracellular Trafficking"
08:20am-08:40am: Mr. Jose Estevam, Head Clinical Biomarkers, Takeda
"Novel and Innovative Application of Mass Cytometry in Clinical Biomarkers"
08:40am-09:00am: Mr. Gregory Hopkins, Senior Associate Scientist II Cellular Analytics Team, Bluebird Bio
"Making Mass Cytometry ‘Clinical Trial Compatible’"
09:00am-09:20am: Mr. Chad Stevens, Senior Scientist BioMedicine Design Department, Pfizer
"Advantages & Challenges in Using Mass Cytometry for Quantitative Biomeasures"
09:20am-09:50am: Dr. Polina Goihberg, Discipline Lead BioMedicine Design Department, Pfizer
Mr. Jose Estevam, Head Clinical Biomarkers, Takeda
Mr. Gregory Hopkins, Senior Associate Scientist II Cellular Analytics Team, Bluebird Bio
Mr. Chad Stevens, Senior Scientist BioMedicine Design Department, Pfizer
"Panel Discussions on Advancements of Mass Cytometry and Imaging Cytometry in Clinical Applications"
09:50am-10:20am: Short Break

Session 2: Current Regulatory Challenges in Flow Cytometry Validation

Chair: Dr. Steve Keller, Senior Director Global Head Biomarker Bioanalysis, AbbVie
10:20am-10:40am: Dr. Steven Eck, Associate Director Integrated Bioanalysis, AstraZeneca
"Recent Developments in Flow Cytometry Validation in a Bioanalytical Lab: Learnings from Case Studies"
10:40am-11:00am: Dr. Christèle Gonneau, Lead Scientist Flow Cytometry, Labcorp
"The Evaluation of Accuracy for Flow Cytometry Applications in Regulated Laboratories"
11:00am-11:20am: Dr. Ulrike Sommer, Senior Principal Scientist Translational Medicine/Biomarker Development, Novartis
"Sensitivity Determination for Flow Cytometry Assays Validation"
11:20am-11:50pm: Dr. Steven Eck, Associate Principal Scientist Translational Sciences, Clinical Immunology and Bioanalysis, AstraZeneca
Dr. Christèle Gonneau, Lead Scientist Flow Cytometry, Labcorp
Dr. Ulrike Sommer, Senior Principal Scientist Translational Medicine/Biomarker Development, Novartis
"Panel Discussions on Current Regulatory Challenges in Flow Cytometry Validation"
11:50am-12:20pm: Short Break

Session 3: Is Spectral Cytometry the next generation of High Dimensional Cytometry?

Chair: Dr. Susan Spitz, Senior Director Translational Sciences, Incyte
12:20pm-12:40pm: Dr. Michael Nathan Hedrick, Director Clinical Flow Cytometry, Bristol Myers Squibb
"Spectral Flow Cytometry: Making Ultra High Order Flow Cytometry Assays Accessible in Clinical Flow Cytometry Assays"
12:40pm-01:00pm: Dr. Vilma Decman, Director and Head Cellular Biomarkers, GlaxoSmithKline
"Recent Advancements in High Dimensional Flow Cytometry"
01:00pm-01:20pm: Dr. Enrique Gomez Alcaide, Translational Biomarker Leader, Roche
"High Dimensional Cytometry Panels in Clinical Trials"
01:20pm-01:50pm: Dr. Michael Nathan Hedrick, Director Clinical Flow Cytometry, Bristol Myers Squibb
Dr. Vilma Decman, Director and Head Cellular Biomarkers, GlaxoSmithKline
Dr. Enrique Gomez Alcaide, Translational Biomarker Leader, Roche
"Panel Discussions on Is Spectral Cytometry the next generation of High Dimensional Cytometry?"
01:50pm-02:20pm: Short Break

Session 4: Evolving Science & Innovation: Multivariate Analytical Techniques & Multiparameter Flow Cytometry

Chair: Dr. Steve Keller, Senior Director Global Head Biomarker Bioanalysis, AbbVie
02:20pm-02:40pm: Dr. Nathan Standifer, Group Director Integrated Bioanalysis, AstraZeneca
"Advanced Applications of Multivariate Analytical Techniques in Flow Cytometry Immunophenotyping Assays"
02:40pm-03:00pm: Dr. Fabian Junker, Principal Scientist Protein Biomarker Development, Roche
"Assessment of Steric Hindrance in Multiparameter Flow cytometry: How to tackle molecular competition in Clinical Biomarker Development?"
03:00pm-03:20pm: Dr. Sandra Nuti, Head High Parametric Flow Cytometry & Immunomonitoring, GlaxoSmithKline
"Characterization of Early Immune Responses in Stabilized Human Whole Blood – Smart Tube PoC"
03:20pm-03:50pm: Dr. Nathan Standifer, Group Director Integrated Bioanalysis, AstraZeneca
Dr. Fabian Junker, Principal Scientist Protein Biomarker Development, Roche
Dr. Sandra Nuti, Head High Parametric Flow Cytometry & Immunomonitoring, GlaxoSmithKline
"Panel Discussions on Evolving Science & Innovation: Multivariate Analytical Techniques & Multiparameter Flow Cytometry"
03:50pm-04:10pm: Short Break

Session 5: 2021 White Paper in Bioanalysis

04:10pm-04:30pm: Dr. Susan Spitz, Senior Director Translational Sciences, Incyte
Dr. Steve Keller, Senior Director Global Head Biomarker Bioanalysis, AbbVie
"Recommendations on Cytometry Innovation Day: Novel Techniques & Advanced Approaches in Cytometry"
04:30pm-05:00pm: Dr. Susan Spitz, Senior Director Translational Sciences, Incyte
Dr. Steve Keller, Senior Director Global Head Biomarker Bioanalysis, AbbVie
"Panel Discussions on 2021 White Paper in Bioanalysis draft Recommendations"
05:00pm-05:20pm: Short Break
05:20pm-06:20pm: Poster Spotlight Sessions with open access to all attendees




Agenda at a Glance Agenda at a Glance